Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Design Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 100 | 2 | 95 | −3 |
| Shares | 32.0M | 37.3K | 33.5M | +1.47M (+4.6%) |
| Value | $172.3M | $200.6K | $206.5M | +$34.3M (+19.9%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Design Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Driehaus Capital Management LLC | 776,082 | $4.79M | 0.04% |
| MPM Oncology Impact Management LP | 559,547 | $3.45M | 0.49% |
| XTX Topco Ltd | 48,424 | $298.8K | 0.03% |
| BNP Paribas Arbitrage, SA | 40,289 | $248.6K | 0.00% |
| Susquehanna International Group, LLP | 37,312 | $230.2K | 0.00% |
| Intech Investment Management LLC | 17,665 | $109.0K | 0.00% |
| Kennedy Capital Management, Inc. | 14,266 | $88.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 12,006 | $74.1K | 0.01% |
| Invesco Ltd. | 11,583 | $71.5K | 0.00% |
| ProShare Advisors LLC | 11,525 | $71.1K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 6,598 | $40.7K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 1,887 | $11.8K | 0.00% |
| GF Fund Management Co. Ltd. | 1,189 | $7.34K | 0.00% |
| Venturi Wealth Management, LLC | 753 | $4.65K | 0.00% |
| CoreCap Advisors, LLC | 712 | $4.39K | 0.00% |
Sold out (18)
Institutions that held Design Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Prescott Group Capital Management, L.L.C. | 343,000 | $1.85M |
| Millennium Management LLC | 207,257 | $1.12M |
| Virtu Financial LLC | 46,356 | $249.0K |
| Ameriprise Financial Inc | 43,245 | $232.7K |
| HSBC Holdings PLC | 31,287 | $168.0K |
| Jane Street Group, LLC | 24,003 | $129.1K |
| Tudor Investment Corp Et Al | 18,738 | $100.8K |
| Marshall Wace, LLP | 17,192 | $92.5K |
| Prelude Capital Management, LLC | 15,985 | $86.0K |
| Paloma Partners Management Co | 11,902 | $64.0K |
| Jump Financial, LLC | 11,000 | $59.2K |
| Public Employees Retirement System of Ohio | 8,272 | $44.5K |
| Federated Hermes, Inc. | 2,988 | $16.1K |
| Group One Trading, L.P. | 1,000 | $5.38K |
| Newbridge Financial Services Group, Inc. | 300 | $1.61K |
| Capital Performance Advisors LLP | 143 | $769 |
| Point72 (DIFC) Ltd | 67 | $362 |
| Covestor Ltd | 20 | $0 |
Not filed for Q4 2024 yet (2)
Institutions that held Design Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| SpiderRock Advisors, LLC | 26,965 | $145.1K |
| AJOVista, LLC | 10,319 | $55.5K |